Austin, TX – Tekton Research proudly announces an innovative collaboration with esteemed Dermatology Specialist Dr. Emily L. Prosise, marking the expansion of clinical research in Austin.
With over two decades of experience in dermatology, Dr. Emily Prosise is a double board-certified Mohs surgeon and a distinguished Fellow of the American Society for Mohs Surgery, specializing in surgical and skin cancer dermatology. Her unwavering commitment to providing exceptional patient care stands as a cornerstone of her practice.
Dr. Prosise brings a distinguished background in evidence-based medicine, starting her journey in medical education within Duke University’s research laboratories. Her tenure as a Howard Hughes Fellow at the National Institutes of Health further fueled her passion for rigorous research. The integration of clinical research at her esteemed practice, Central Texas Dermatology, in partnership with Tekton, seamlessly aligns with her dedication to scientific exploration.
Emily L. Prosise, M.D.
“Through clinical research, we are innovating patient care with groundbreaking solutions. My partnership with Tekton Research signifies a pivotal step toward advancing global dermatological care. It not only fuels innovation but also strengthens our ties within the Austin community that Central Texas Dermatology serves.” Says Dr. Prosise.
Beyond her clinical pursuits, Dr. Prosise is a passionate advocate for nurturing the next generation of dermatologists. Her influential roles as Chief Resident at Stanford University and as a clinical assistant professor at prestigious institutions like New York University and the University of California, Irvine, underscore her commitment to advancing medical education. Dr. Prosise’s altruism extends to volunteer work in the dermatology surgery unit at Dell Medical School, along with contributions to skin cancer screening clinics. Her compassionate endeavors reach globally through her work with underprivileged children in Nicaragua and ongoing support for educational initiatives in Managua.
Tekton Research welcomes Dr. Emily L. Prosise, whose enthusiastic approach marks the beginning of a collaborative journey. Their shared commitment to pioneering clinical research and ensuring unparalleled patient satisfaction stands as a resolute mission. Together, they aim to elevate lives through groundbreaking advancements in clinical research.
For further information or to schedule a meeting with Tekton’s Business Development team, please contact letsmeet@tektonresearch.flywheelstaging.com.
